Literature DB >> 26337107

Emerging Vascular Risk Factors in Women: Any Differences from Men?

N Katsiki, D P Mikhailidis1.   

Abstract

Gender differences have been reported for traditional vascular risk factors such as smoking, obesity, diabetes, hypertension, dyslipidemia, age and family history of premature coronary heart disease. The prevalence, severity, associations and response to treatment of several emerging cardiovascular disease (CVD) risk factors may also differ between men and women. Such CVD risk factors include certain inflammatory and hemostatic markers, endothelial dysfunction, homocysteine, lipid disorders, microalbuminuria/proteinuria, coronary artery calcium score, arterial stiffness, periodontitis, inflammatory bowel syndrome, obstructive sleep apnea, impaired glucose metabolism, metabolic syndrome and non-alcoholic fatty liver disease. Further larger prospective studies are needed to establish these relationships. Hormone replacement therapy may also affect vascular risk. These data should be taken into consideration when assessing and treating CVD risk in women.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26337107     DOI: 10.2174/0929867322666150904110053

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  5 in total

1.  Association of renal hyperfiltration with incident proteinuria - A nationwide registry study.

Authors:  Seung Min Lee; Ju-Young Park; Min-Su Park; Jong Heon Park; Minseon Park; Hyung-Jin Yoon
Journal:  PLoS One       Date:  2018-04-13       Impact factor: 3.240

2.  STOP-Bang questionnaire screening for obstructive sleep apnea among Chinese patients with type 2 diabetes mellitus.

Authors:  Yunjie Teng; Shuxia Wang; Ning Wang
Journal:  Arch Med Sci       Date:  2018-03-02       Impact factor: 3.318

3.  Characterization of Early-Stage Alcoholic Liver Disease with Hyperhomocysteinemia and Gut Dysfunction and Associated Immune Response in Alcohol Use Disorder Patients.

Authors:  Vatsalya Vatsalya; Khushboo S Gala; Ammar Z Hassan; Jane Frimodig; Maiying Kong; Nachiketa Sinha; Melanie L Schwandt
Journal:  Biomedicines       Date:  2020-12-24

4.  Serum homocysteine is associated with tubular interstitial lesions at the early stage of IgA nephropathy.

Authors:  Zizhen Li; Qianqian Han; Hongbo Ye; Jiajia Li; Xiaona Wei; Rui Zhang; Qiuyan Huang; Yanchun Xu; Guanxian Liu; Bin Li; Qiongqiong Yang
Journal:  BMC Nephrol       Date:  2022-02-23       Impact factor: 2.388

5.  Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome.

Authors:  Giuseppina Piazzolla; Mafalda Candigliota; Margherita Fanelli; Anna Castrovilli; Elsa Berardi; Gianfranco Antonica; Stefano Battaglia; Vincenzo Solfrizzi; Carlo Sabbà; Cosimo Tortorella
Journal:  Diabetol Metab Syndr       Date:  2019-10-26       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.